A Case of Capecitabine-induced Hyperpigmentation and Radiation Recall Phenomenon

Clinical Oncology

Volumn 21, Issue 8, 2009, Pages 632-

  Ghosal, N ^a   Misra, V ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FULVESTRANT; LETROZOLE; NAVELBINE; PACLITAXEL;

ADJUVANT THERAPY; ADULT; BONE METASTASIS; BREAST CARCINOMA; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; HUMAN; HYPERPIGMENTATION; LETTER; LIVER METASTASIS; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PLEURA METASTASIS; PRIORITY JOURNAL; RADIATION DERMATITIS;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; HYPERPIGMENTATION;

EID: 69449088286     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.02.007     Document Type: Letter

References (5)

1. Ortmann E., and Hohenberg G. Radiation recall phenomenon after administration of capecitabine. J Clin Oncol 20 (2002) 3029
2. Camidge R., and Price A. Characterising the phenomenon of radiation recall dermatitis. Radiother Oncol 59 (2001) 237-245
3. Vázquez-Bayo C., Rodriquez-Bujaldon A.L., Jimenez-Puya R., Galan-Gutierrez M., and Moreno-Giminez J.C. Capecitabine-induced hyperpigmentation. Actas Dermosifiliogr 98 7 (2007) 491-493 (in Spanish with full English translation)
4. Pui J.C., Meehan S., and Moskovits T. Capecitabine induced cutaneous hyperpigmentation: report of a case. J Drugs Dermatol 2 (2002) 202-205
5. Sendur M.A.N., and Kilickap S. Stevens-Johnson syndrome after treatment with capecitabine. Clin Oncol 20 (2008) 202-203